Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Expands By 18.4%

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 361,200 shares, a growth of 18.4% from the October 15th total of 305,100 shares. Based on an average daily trading volume, of 155,500 shares, the days-to-cover ratio is currently 2.3 days. Currently, 1.1% of the company’s shares are sold short.

Insider Buying and Selling at Viemed Healthcare

In other Viemed Healthcare news, Director Nitin Kaushal sold 30,000 shares of the business’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the transaction, the director now owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. The trade was a 19.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the completion of the sale, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 20.00% of the company’s stock.

Institutional Trading of Viemed Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in VMD. Vanguard Group Inc. increased its stake in shares of Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after buying an additional 617,009 shares during the period. Apis Capital Advisors LLC increased its position in Viemed Healthcare by 193.0% in the 2nd quarter. Apis Capital Advisors LLC now owns 234,400 shares of the company’s stock valued at $1,535,000 after acquiring an additional 154,400 shares during the period. Russell Investments Group Ltd. raised its stake in shares of Viemed Healthcare by 5.3% during the first quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock valued at $1,386,000 after acquiring an additional 7,386 shares during the last quarter. Pinnacle Wealth Planning Services Inc. acquired a new position in shares of Viemed Healthcare during the first quarter worth $135,000. Finally, Price T Rowe Associates Inc. MD bought a new stake in shares of Viemed Healthcare in the first quarter worth $97,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of NASDAQ VMD traded down $0.14 during mid-day trading on Friday, reaching $8.92. 116,909 shares of the company were exchanged, compared to its average volume of 153,938. The stock has a market capitalization of $347.32 million, a P/E ratio of 33.48 and a beta of 1.43. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. Viemed Healthcare has a twelve month low of $6.21 and a twelve month high of $10.44. The company’s 50-day simple moving average is $8.31 and its 200-day simple moving average is $7.53.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $58.00 million for the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.